HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Novel Thrombectomy Catheter Targets Deep Vein Thrombosis

By HospiMedica International staff writers
Posted on 16 Dec 2015
Print article
The AngioJet ZelanteDVT thrombectomy catheter
The AngioJet ZelanteDVT thrombectomy catheter (Photo courtesy of )
A new thrombectomy catheter has been specifically designed to treat deep vein thrombosis (DVT) in large-diameter upper and lower peripheral veins.

The AngioJet ZelanteDVT thrombectomy catheter is indicated for the disruption and removal of large venous clot burdens from iliofemoral and lower extremity veins greater than or equal to 6 mm in diameter, and upper extremity peripheral veins greater than or equal to 6 mm in diameter. The 8 F (2.7 mm) catheter is the largest and strongest thrombectomy catheter in the AngioJet portfolio, with four times the thrombus removal power of previous generation catheters, and is used in conjunction with the AngioJet Ultra Console.

The 105 centimeters long thrombectomy catheter, which utilizes an over-the-wire guidewire and sheath for delivery, is torqueable and directional, enabling rapid thrombus removal, and is also PowerPulse enabled for the infusion of physician-specified fluids, including thrombolytic agents into the peripheral vascular system. The AngioJet ZelanteDVT thrombectomy catheter is a product of Boston Scientific (Natick, MA, USA), and has been approved by the US Food and Drug Administration (FDA).

“The new features of the ZelanteDVT catheter represent our focus on improving procedural efficiencies and reducing the economic burden associated with this challenging condition,” said Jeff Mirviss, peripheral interventions president at Boston Scientific. “With this addition to our AngioJet portfolio, we are further evolving the current suite of life-changing therapeutic options available to physicians and their patients with deep vein thrombosis.”

DVT commonly affects peripheral veins (such as the femoral vein, the popliteal vein, or the iliofemoral vein), and can occur without any symptoms. In many cases the affected extremity will be painful, swollen, red, and warm, and the superficial veins may be engorged. The most serious complication of a DVT is that the clot could dislodge and cause a pulmonary embolism (PE). DVT is a medical emergency and untreated lower extremity DVT has a 3% PE-related mortality rate.

Related Links:

Boston Scientific


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Compact C-Arm
Arcovis DRF-C S21
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more